{"entity":{"type":"insider","cik":"0001801385","url":"/insider/0001801385","json_url":"/insider/0001801385.json","name":"ROMANO KATHRYN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":44,"n_filings":8,"first":"2023-05-23","last":"2026-03-03","span_basis":"filed_date"},"name_variants":[{"name":"ROMANO KATHRYN","source":"filing","n_filings":6,"first_seen":"2024-02-28","last_seen":"2026-03-03"},{"name":"Romano Kathryn","source":"filing","n_filings":2,"first_seen":"2023-05-23","last_seen":"2024-01-24"}],"transactions":[{"id":5989807,"accession":"0001801385-26-000002","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001801385-26-000002","line_url":"/filing/0001801385-26-000002#line-5","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001801385","owner_name":"ROMANO KATHRYN","owner_display_name":"ROMANO KATHRYN","owner_url":"/insider/0001801385","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":267.6,"price_display":"267.60","price_state":"stated","total_value":200700.0,"total_display":"200,700.00","total_whole":"200,700","shares_owned_after":22366.0,"shares_owned_after_display":"22,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider"},{"id":5767296,"accession":"0001711279-26-000011","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001711279-26-000011","line_url":"/filing/0001711279-26-000011","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001801385","owner_name":"ROMANO KATHRYN","owner_display_name":"ROMANO KATHRYN","owner_url":"/insider/0001801385","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":272.136412576,"price_display":"272.14","price_state":"stated","total_value":3401705.1572,"total_display":"3,401,705.16","total_whole":"3,401,705","shares_owned_after":24118.0,"shares_owned_after_display":"24,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-09","filed_date":"2026-02-11","scope":"insider","n_lines":7},{"id":5178466,"accession":"0001801385-25-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001801385-25-000002","line_url":"/filing/0001801385-25-000002#line-2","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001801385","owner_name":"ROMANO KATHRYN","owner_display_name":"ROMANO KATHRYN","owner_url":"/insider/0001801385","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":175.22,"price_display":"175.22","price_state":"stated","total_value":131415.0,"total_display":"131,415.00","total_whole":"131,415","shares_owned_after":12604.0,"shares_owned_after_display":"12,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-27","filed_date":"2025-02-28","scope":"insider"},{"id":2708515,"accession":"0001801385-24-000009","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001801385-24-000009","line_url":"/filing/0001801385-24-000009","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001801385","owner_name":"ROMANO KATHRYN","owner_display_name":"ROMANO KATHRYN","owner_url":"/insider/0001801385","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":166.05076133333333,"price_display":"166.05","price_state":"stated","total_value":1245380.71,"total_display":"1,245,380.71","total_whole":"1,245,381","shares_owned_after":12936.0,"shares_owned_after_display":"12,936","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-28","filed_date":"2024-03-01","scope":"insider","n_lines":15},{"id":2444952,"accession":"0001801385-24-000011","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001801385-24-000011","line_url":"/filing/0001801385-24-000011","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001801385","owner_name":"ROMANO KATHRYN","owner_display_name":"ROMANO KATHRYN","owner_url":"/insider/0001801385","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":165.88337784,"price_display":"165.88","price_state":"stated","total_value":829416.8892,"total_display":"829,416.89","total_whole":"829,417","shares_owned_after":12936.0,"shares_owned_after_display":"12,936","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-28","filed_date":"2024-03-01","scope":"insider","n_lines":8},{"id":2328633,"accession":"0001801385-24-000007","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001801385-24-000007","line_url":"/filing/0001801385-24-000007","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001801385","owner_name":"ROMANO KATHRYN","owner_display_name":"ROMANO KATHRYN","owner_url":"/insider/0001801385","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8087.0,"shares_display":"8,087","price_per_share":136.9086187708668,"price_display":"136.91","price_state":"stated","total_value":1107180.0,"total_display":"1,107,180.00","total_whole":"1,107,180","shares_owned_after":12556.0,"shares_owned_after_display":"12,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-26","filed_date":"2024-02-28","scope":"insider","n_lines":2},{"id":2664596,"accession":"0001801385-24-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001801385-24-000002","line_url":"/filing/0001801385-24-000002#line-2","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001801385","owner_name":"Romano Kathryn","owner_display_name":"Romano Kathryn","owner_url":"/insider/0001801385","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":130.0,"price_display":"130.00","price_state":"stated","total_value":325000.0,"total_display":"325,000.00","total_whole":"325,000","shares_owned_after":12556.0,"shares_owned_after_display":"12,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-22","filed_date":"2024-01-24","scope":"insider"},{"id":8641362,"accession":"0001801385-23-000004","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001801385-23-000004","line_url":"/filing/0001801385-23-000004","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001801385","owner_name":"Romano Kathryn","owner_display_name":"Romano Kathryn","owner_url":"/insider/0001801385","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":109.039683092,"price_display":"109.04","price_state":"stated","total_value":2725992.0773,"total_display":"2,725,992.08","total_whole":"2,725,992","shares_owned_after":12556.0,"shares_owned_after_display":"12,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-22","filed_date":"2023-05-23","scope":"insider","n_lines":6},{"id":8641328,"accession":"0001801385-23-000004","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001801385-23-000004","line_url":"/filing/0001801385-23-000004","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001801385","owner_name":"Romano Kathryn","owner_display_name":"Romano Kathryn","owner_url":"/insider/0001801385","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28428.0,"shares_display":"28,428","price_per_share":95.0514715210356,"price_display":"95.05","price_state":"stated","total_value":2702123.2324,"total_display":"2,702,123.23","total_whole":"2,702,123","shares_owned_after":15984.0,"shares_owned_after_display":"15,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-19","filed_date":"2023-05-23","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":44,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":44,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":44},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001711279","name":"Krystal Biotech, Inc.","url":"/issuer/0001711279","role":"Officer (Chief Accounting Officer)","n_filings":8,"first_seen":"2023-05-23","last_seen":"2026-03-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001801385","retrieved_at":"2026-08-26T02:57:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}